However, as this study did not specify the exact purpose of B2AR agonist prescriptions, it seems likely that these agonists were rather prescribed for the treatment of asthma, given that such B2ARs were chosen based on the outpatient prescriptions. The gene discussed is ADRB2; the disease is asthma.